Lipid nanoparticles (LNPs) are gaining attention as effective drug delivery vehicles, especially since their successful use in the COVID-19 vaccines. …
Read Post
A central challenge with particle analysis in biotherapeutics is the wide size range of particles that may be present, including particles from the …
Read Post
The Alexander Laskin Research Group at Purdue University is a "multi-disciplinary experimental group with research interests in the areas of …
Read Post
Particles are ubiquitous in biotherapeutics and can drastically impact the efficacy of a given drug. Therefore, characterizing them is a critical …
Read Post
In microscope systems, the numerical aperture and the wavelength of the light determine how highly-resolved the images will be (in the case of …
Read Post
Many new types of biotherapeutic Active Pharmaceutical Ingredients (API) such as viruses, nanomedicines including virus-like particles and lipid …
Read Post
In a recent paper discussing particle counting and analytical techniques, the number and type of particles present in intravitreal injection …
Read Post
Last week, The-Scientist.com introduced their new Research Products blog. Their very first post discusses the capabilities of the FlowCam Nano:
Read Post
Characterization of subvisible particles in protein therapeutics has become an increasingly important means to ensure the development of safe, …
Read Post
December 2018 — A recent study by researchers from the University of New England and University of New Hampshire has demonstrated that flow imaging …
Read Post
Biopharmaceutical manufacturers strive to ensure patient safety, avoid recalls and protect company reputations. Identifying subvisible particles is …
Read Post